CONTINUE TO SITE ➞

Don't miss tomorrow's biopharma industry news

Let BioPharma Dive's free newsletter keep you informed, straight from your inbox.

Daily Dive M-F

Commercialization Weekly Every Wednesday

Gene Therapy Weekly Every Thursday

Emerging Biotech Weekly Every Tuesday

By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime.

Deep Dive
Library
Events
Press Releases

Pharma
Biotech
FDA
Clinical Trials
Deals
Drug Pricing
Gene Therapy

What We're Reading: Page 216

Industry reads hand-picked by our editors

Nov 13, 2019

Nature
‘Make Ebola a thing of the past’: First vaccine against deadly virus approved
Axios
Wall Street is selling off a major specialty pharmacy
Bloomberg
Mental Health Is Still a 'Don't Ask, Don't Tell' Subject at Work
BioCentury
Three late-stage wins shift the clinical landscape in SLE

Nov 12, 2019

Science
Untangling the Trump administration’s lawsuit over an HIV prevention drug
BioCentury
Safety concerns overshadow efficacy highlights in MyoKardia’s cardiomyopathy data
The Wall Street Journal
Google’s ‘Project Nightingale’ Gathers Personal Health Data on Millions of Americans

Nov 11, 2019

Regulatory Focus
Orphan Drug Recall Leaves Patients in the Lurch
OneZero
Ambrosia, the Young Blood Transfusion Startup, Is Quietly Back in Business
C&EN
C&EN's 2019 10 Start-Ups to Watch
The Wall Street Journal
China’s Drug Market Is Opening Up

Nov 08, 2019

The Washington Post
At height of crisis, Walgreens handled one in five of the most addictive opioids
STAT
A medicinal chemist sees some red flags on China's new Alzheimer's drug
Bloomberg
With Vape Curbs Pending, White House Questions FDA Tobacco Role

Nov 07, 2019

The Wall Street Journal
A New Strain of HIV Is Recorded Under Group That Caused Pandemic
Reuters
Judge shields OxyContin-maker Purdue from litigation until April
C&EN
Amping up the pharma lab: Drug companies explore the potential of electrochemistry

Nov 06, 2019

Associated Press
Doctors try CRISPR gene editing for cancer, a 1st in the US
In the Pipeline
More, Unfortunately, on the Chinese Alzheimer's Drug Approval
Bloomberg
Woodford’s Woes Cast a Pall Over British Early Biotech Industry

Nov 05, 2019

The New York Times
Why Didn’t She Get Alzheimer’s? The Answer Could Hold a Key to Fighting the Disease
The Wall Street Journal
Obscure Model Puts a Price on Good Health—and Drives Down Drug Costs
STAT
Faced with Biogen's Alzheimer's drug, panel would wield huge influence

Previous Next

Get the free newsletter

Subscribe to BioPharma Dive for top news, trends & analysis

Email:

Select Newsletter: Daily Dive M-F
Select Newsletter: Commercialization Weekly Every Wednesday
Select Newsletter: Gene Therapy Weekly Every Thursday
Select Newsletter: Emerging Biotech Weekly Every Tuesday
Select user consent: By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime.

A valid email address is required. Please select at least one newsletter.

Library resources

Trendline
Inside the world of cell therapies Supported by ProBio CDMO
Trendline
Inside the market strategies of today’s drugmakers Supported by Evaluate
Trendline
The latest developments on the gene therapy frontier Supported by Mirus Bio LLC

View all

Company Announcements

View all | Post a press release

Events

View all | Promote an event

Industry Intel

Revolutionizing Next Generation Gene Therapies with On-Demand Large DNA Construct Synthesis and Novel, Designable Delivery Vehicles Webinar - on demand • Provided by Ansa Biotechnologies
Developing an Array of Diverse Vaccine Platforms Webinar - on demand • Provided by BioPharma Dive's studioID; Sponsored content by Novavax in partnership with studioID
Top Ways that AI Will Change Life Sciences Webinar - on demand • Provided by Salesforce

Explore

About
Editorial Team
Contact Us
Newsletter
Purchase Licensing Rights
Press Releases
What We're Reading

Reach our audience

Advertising
Post a press release
Promote an event

Related Publications

Healthcare Dive
MedTech Dive

Industry Dive is an Informa TechTarget business.

This website is owned and operated by Informa TechTarget, part of a global network that informs, influences and connects the world's technology buyers and sellers. All copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. TechTarget, Inc.'s registered office is 275 Grove St. Newton, MA 02466.

Home
- Pharma
- Biotech
- FDA
- Clinical Trials
- Deals
- Drug Pricing
- Gene Therapy
Deep Dive
Library
Events
Press Releases

Get BioPharma Dive in your inbox

The free newsletter covering the top industry headlines

Email:

Select Newsletter: Daily Dive M-F
Select Newsletter: Commercialization Weekly Every Wednesday
Select Newsletter: Gene Therapy Weekly Every Thursday
Select Newsletter: Emerging Biotech Weekly Every Tuesday
Select user consent: By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime.

A valid email address is required. Please select at least one newsletter.